Patents Examined by Amy M Bunker
  • Patent number: 10329607
    Abstract: The invention provides methods, devices, compositions and kits for diagnosing or predicting transplant status or outcome in a subject who has received a transplant.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: June 25, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Stephen R. Quake, Thomas M. Snyder, Hannah Valantine
  • Patent number: 10316354
    Abstract: A two-electrode detection system having target substrates including nucleic acids, proteins, and/or small molecules on specifically defined regions of a single surface. The spatial distribution of the target substrate on the surface allows for more accurate substrate interactions and analysis. Additionally, the detection system of the present invention allows for patterning of different target substrates, thereby affording more accurate analysis of multiple substrate targets.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: June 11, 2019
    Assignee: California Institute of Technology
    Inventors: Ariel L. Furst, Michael G. Hill, Natalie B. Muren, Jacqueline K. Barton
  • Patent number: 10316000
    Abstract: The present invention relates to novel fluorophores and their use in combination with novel nucleic acid molecules, called aptamers, that bind specifically to the fluorophore and thereby enhance the fluorescence signal of the fluorophore upon exposure to radiation of suitable wavelength. Molecular complexes formed between the novel fluorophores, novel nucleic acid molecules, and their target molecules are described, and the use of multivalent aptamer constructs as fluorescent sensors for target molecules of interest are also described.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: June 11, 2019
    Assignee: Cornell University
    Inventors: Samie R. Jaffrey, Jeremy S. Paige
  • Patent number: 10288607
    Abstract: An article such as a biomolecular detector or biosensor having a nonfouling surface thereon includes: (a) a substrate having a surface portion; (b) a linking layer on the surface portion; and (c) a polymer layer formed on the linking layer; and (d) a first member of a specific binding pair (e.g., a protein, peptide, antibody, nucleic acid, etc.) bound to the polymer layer. Methods of making and using the articles are also described.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 14, 2019
    Assignee: Sentilus Holdco LLC
    Inventors: Ashutosh Chilkoti, Angus Hucknall
  • Patent number: 10274488
    Abstract: Aluminum coated glass slides provide a novel glycan array platform. Specifically, aluminum coated glass slides increase sensitivity of fluorescent based assay methods. Additionally, aluminum coated glass slides allows for mass spectroscopic analysis of carbohydrates and provide a platform for examining activity of cellulases. The unique properties of ACG slides include: 1) the metal oxide layer on the surface can be activated for grafting organic compounds such as modified oligosaccharides; 2) the surface remains electrically conductive, and the grafted oligosaccharides can be simultaneously characterized by mass spectrometry and carbohydrate-binding assay; and 3) the slides are more sensitive than transparent glass slides in binding analysis.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: April 30, 2019
    Assignee: ACADEMIA SINICA
    Inventors: Chi-Huey Wong, Chung-Yi Wu, Susan Y. Tseng
  • Patent number: 10267811
    Abstract: The present invention provides a rapid, sensitive method for forensic drug testing in a post-mortem subject using oral fluid collected from the post-mortem subject. The method comprises collecting a sample of oral fluid from a post-mortem subject, analyzing the oral fluid sample qualitatively to detect the presence of one or more non-naturally occurring drugs, analyzing the oral fluid sample quantitatively to determine concentration of the one or more non-naturally occurring drugs in the post-mortem subject, and identifying the one or more non-naturally occurring drugs in the post-mortem subject. The detection and quantification in oral fluid is more sensitive and faster than detection and quantification of the non-naturally occurring drugs in blood, urine, bile, and liver tissue collected from the same post-mortem subject. Further, the qualitative and quantitative results are obtained in as little as three hours.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: April 23, 2019
    Inventor: Amy J. Reisinger
  • Patent number: 10240180
    Abstract: Disclosed herein are methods, compositions and systems for analyzing and detecting enzyme activity. For examples, methods, compositions and systems for parallel detection and analysis of enzymatic activities of enzymes in complex biological mixtures are provided.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: March 26, 2019
    Assignees: The Regents of the University of California, National Technology & Engineering Solutions of Sandia, LLC
    Inventors: Trent R. Northen, Wolfgang E. Reindl, Kai Deng, Seema Singh, Anup K. Singh, Xiaoliang Cheng
  • Patent number: 10240194
    Abstract: Methods of obtaining sequence information about target polynucleotide having a predefined sequence are disclosed. The methods include sequencing by ligation and sequencing by polymerase.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: March 26, 2019
    Assignee: Gen9, Inc.
    Inventors: Joseph Jacobson, Daniel Schindler
  • Patent number: 10241045
    Abstract: Spectrally encoded microbeads and methods and devices for making and using spectrally encoded microbeads are provided. The disclosed methods and devices facilitate the preparation and use of microbeads containing multiple lanthanide nanoparticles, which microbeads have uniquely identifiable spectral codes. The disclosed microbeads, and the methods and devices for making and using same, find use in multiplexing and high-throughput biomarker analysis.
    Type: Grant
    Filed: August 22, 2013
    Date of Patent: March 26, 2019
    Assignee: The Regents of the University of California
    Inventors: Brian Cullen Baxter, Joseph L. Derisi, Polly M. Fordyce, Rachel E. Gerver, Rafael Gòmez-Sjöberg, Brett A. Helms, Kurt S. Thorn, Ronald N. Zuckermann
  • Patent number: 10221412
    Abstract: The present invention relates to a multiplex microfluidic device for selection of nucleic acid aptamers and a method for high-throughput selection of nucleic acid aptamers using the same, and more particularly to a multiplex microfluidic device (SELEX lap-on-a-chip) that uses an improved multiplex platform in place of the development of an aptamer for a single target and to a method for high throughput selection of aptamers using the same together with high-throughput sequencing. A multiplex microfluidic device according to the present invention can simultaneously detect aptamers for a plurality of targets, and it can greatly increase the screening throughput and greatly shorten the process time compared to conventional multiplex techniques.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: March 5, 2019
    Assignees: PCL, INC., DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: So Youn Kim, Ji-Young Ahn, Minjoung Jo, Tae Kyung Kim
  • Patent number: 10208305
    Abstract: Methods relating to obtaining libraries of YY1-binding long non-coding RNAs, libraries obtained thereby, and methods of use thereof.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: February 19, 2019
    Assignee: The General Hospital Corporation
    Inventors: Jeannie T. Lee, Yesu Jeon
  • Patent number: 10207240
    Abstract: Methods and devices are provided for manipulating droplets on a support using surface tension properties, moving the droplets along a predetermined path and merging two droplets together enabling a number of chemical reactions. Disclosed are methods for controlling the droplets volumes. Disclosed are methods and devices for synthesizing at least one oligonucleotide having a predefined sequence. Disclosed are methods and devices for synthesizing and/or assembling at least one polynucleotide product having a predefined sequence from a plurality of different oligonucleotides having a predefined sequence.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: February 19, 2019
    Assignee: Gen9, Inc.
    Inventors: Joseph Jacobson, Larry Li-Yang Chu, Senthil Ramu
  • Patent number: 10151698
    Abstract: The invention describes a method for the identification of compounds which bind to a target component of a biochemical system or modulate the activity of the target, by compartmentalizing the compounds into microcapsules together with the target, such that only a subset of the repertoire is represented in multiple copies in any one microcapsules; and identifying the compound which binds to or modulates the activity of the target. The invention enables the screening of large repertoires of molecules which can serve as leads for drug development.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: December 11, 2018
    Assignee: United Kingdom Research and Innovation
    Inventors: Andrew David Griffiths, Chris Abell, Florian Hollfelder, Enrico Mastrobattista
  • Patent number: 10144945
    Abstract: A layered, microfluidic living cell array is disclosed. The cell array comprises a first layer comprising at least one cell culture channel; a second layer comprising at least one microfluidic channel; and a third layer, disposed between the first layer and the second layer. The third layer comprises a filter membrane with a plurality of pores, each pore fluidly connecting the microfluidic channel to the cell culture channel.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: December 4, 2018
    Assignees: Research Foundation of the City University of New York, Memorial Sloan Kettering Cancer Center
    Inventors: Sihong Wang, Zeynep Dereli-Korkut, Xuejun Jiang
  • Patent number: 10138264
    Abstract: The invention relates to novel molecules and libraries thereof as well as methods for their production. Methods of producing the novel molecules include the cleaving of starting molecules into molecular subunits and the assembly of the subunits into novel recombined molecules.
    Type: Grant
    Filed: March 2, 2011
    Date of Patent: November 27, 2018
    Assignee: VALENT TECHNOLOGIES LLC
    Inventor: Dennis M. Brown
  • Patent number: 10071358
    Abstract: Provided are a novel antibiotic preparation method and platform system based on the method, belonging to a novel drug development method. The method is based on a fixed structural formula: F—R, wherein F is an effect area, and R is an identification area. At the prior art level, the present invention can quickly develop a specific novel antibiotic for most pathogenic microorganisms or biological cells. Also provided is a platform for implementing the method, ensuring that the novel antibiotic is developed in an efficient streamlined process.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: September 11, 2018
    Assignee: PROTEIN DESIGN LAB, LTD.
    Inventor: Xiaoqing Qiu
  • Patent number: 10052605
    Abstract: Methods for use in the synthesis and identification of molecules which bind to a target component of a biological system or modulate the activity of a target are described.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: August 21, 2018
    Assignee: Medical Research Council
    Inventors: Andrew David Griffiths, Chris Abell, Florian Hollfelder, Enrico Mastrobattista
  • Patent number: 10048245
    Abstract: Devices and methods for detecting a target molecule are provided herein. The methods entail contacting a sample with a polymer scaffold, the polymer comprising at least one association site configured to associate with the target molecule. The sample is brought into contact with the polymer to determine whether the target molecule is present in the sample under conditions allowing the target molecule, if present, to associate with the polymer scaffold. The methods further involve loading the polymer into a device comprising a pore or channel that connects two volumes, configuring the device to pass the polymer through the pore or channel from one volume to the other volume, and determining, with a sensor configured to detect objects passing through the pore or channel, whether the target molecule is associated with the association site, and thereby detecting the presence or absence of the target molecule in the sample.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: August 14, 2018
    Assignee: Two Pore Guys, Inc.
    Inventors: Trevor J. Morin, Daniel Alexander Heller, William B. Dunbar
  • Patent number: 10036070
    Abstract: The invention relates to methods of typing a sample from a colorectal cancer patient based on the levels of RNA expression products in a cancer cell of the patient. The invention further relates to methods for determining a strategy for treatment of a patient suffering from colorectal cancer, and to methods for assigning treatment to a patient suffering from colorectal cancer.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: July 31, 2018
    Assignee: AGENDIA N.V.
    Inventors: Paul Roepman, Iris Simon, Tian Sun
  • Patent number: 10030261
    Abstract: The present invention relates to methods and products for the localized or spatial detection of nucleic acid in a tissue sample and in particular to a method for localized detection of nucleic acid in a tissue sample comprising: (a) providing an array comprising a substrate on which multiple species of capture probes are directly or indirectly immobilized such that each species occupies a distinct position on the array and is oriented to have a free 3? end to enable said probe to function as a primer for a primer extension or ligation reaction, wherein each species of said capture probe comprises a nucleic acid molecule with 5? to 3?: (i) a positional domain that corresponds to the position of the capture probe on the array, and (ii) a capture domain; (b) contacting said array with a tissue sample such that the position of a capture probe on the array may be correlated with a position in the tissue sample and allowing nucleic acid of the tissue sample to hybridize to the capture domain in said capture probes;
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: July 24, 2018
    Assignee: SPATIAL TRANSCRIPTOMICS AB
    Inventors: Jonas Frisen, Patrik Ståhl, Joakim Lundeberg